Schizophrenia ResearchNeurosciencePeer-reviewed journal article
Dopamine D1 receptor availability is not associated with delusional ideation measures of psychosis proneness
Granville James MathesoniD, Pontus Plavén‐SigrayiD, Anaïs LouzoloiD, Jacqueline BorgiD, Lars FardeiD, Predrag PetrovićiD, Simon ČervenkaiD
Abstract
The dopamine D1 receptor (D1R) is thought to play a role in psychosis and schizophrenia, however the exact nature of this involvement is not clear. Positron emission tomography studies comparing D1R between patients and control subjects have produced inconsistent results. An important confounding factor in most clinical studies is previous exposure to antipsychotic treatment, which is thought to influence the density of D1R. To circumvent some of the limitations of clinical studies, an alternative approach for studying the relationship between D1R and psychosis is to examine individuals at increased risk for psychotic disorders, or variation in subclinical psychotic symptoms such as delusional ideation within the general population, referred to as psychosis proneness traits. In this study, we investigated whether D1R availability is associated with delusional ideation in healthy controls using data from 76 individuals measured with PET using [11C]SCH23390 and 217 individuals who completed delusional ideation questionnaires, belonging to three different study cohorts. We first performed exploratory, hypothesis-generating, analyses by creating and evaluating a new measure of delusional ideation (n=132 and n=27), which was then found to show a negative association with D1R availability (n=24). Next, we performed confirmatory analyses using Bayesian statistical modelling, in which we first attempted to replicate this result (n=20), and then evaluated the association of Peters Delusion Inventory scores with D1R availability in two independent cohorts (n=41 and 20). Collectively, we found strong evidence that there is little to no linear association between delusional ideation and D1R availability in healthy controls. If differences in D1R can be confirmed in drug-naive schizophrenia patients compared to controls, further studies are needed to ascertain whether these changes occur at the onset of psychotic symptoms or if they are associated with specific behavioural or genetic aspects of psychosis proneness other than delusional ideation.
- Citations
- 3
- FWCI
- 0.36
- Field percentile
- top 41%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Blunted fear-evoked striatal dopamine release in individuals with a family history of psychosis
Rami Hamati, Cecelia Shvetz, … Lauri J. Tuominen·bioRxiv·Aug 27, 2026
- Alterations in type 2 dopamine receptors across neuropsychiatric conditions: A large-scale PET cohort
Tuulia Malén, Severi Santavirta, … Lauri Nummenmaa·NeuroImage ClinicalPeer-reviewed·Jan 1, 2024
- Aberrant type 2 dopamine receptor availability in criminal psychopathy
Lasse Lukkarinen, Jouni Tuisku, … Lauri Nummenmaa·bioRxiv·Jun 21, 2023
- Is dopamine D1 receptor availability related to social behavior? A positron emission tomography replication study
Pontus Plavén‐Sigray, Granville James Matheson, … Simon Červenka·PLoS ONEPeer-reviewed·Mar 15, 2018
- Dopaminergic mechanisms underlying the expression of antipsychotic-induced dopamine supersensitivity in rats
A. Servonnet, F. Allain, … A.-N. Samaha·bioRxiv·Sep 8, 2020
- Modulating D1 rather than D2 receptor-expressing spiny-projection neurons corresponds to optimal antipsychotic effect
Seongsik Yun, Ben Yang, … Jones G. Parker·Nature NeurosciencePeer-reviewed·Jul 13, 2023